Laserfiche WebLink
conduct onsite and follow -up monitoring, and other <br />audits /reviews as necessary, to ensure that: <br />a) Subgrantee meets federal performance goals, <br />administrative and financial management standards, and <br />other requirements applicable to Grant; and <br />b) Funds allocated to Subgrantee are expended for the <br />purposes identified in federal law for allowable and <br />allocable costs in accordance with federal OMB <br />requirements. <br />c. The federal government and Subgrantor shall provide Subgrantee <br />reasonable advance written notice of on -site monitoring reviews of <br />Subgrantee's program or fiscal performance. Subgrantee shall <br />cooperate with the Inspector General and Subgrantor's program and <br />audit staff and other representatives, and provide access to all <br />programs, records, documents, resources, personnel, inventory, and <br />other things reasonably related to the administration and <br />implementation of the services and activities funded directly or <br />indirectly by this Agreement; <br />d. In the event it is determined that Subgrantee is not in compliance with <br />material or other legal requirements of this Agreement, Subgrantor <br />shall provide Subgrantee with observations, recommendations, and /or <br />findings of noncompliance in writing, along with specific action plans <br />for correcting the noncompliance; <br />e. Collection of Disallowed Costs <br />I. In the event questioned costs are identified in a final decision on <br />cost disallowance issued by the federal government or <br />Subgrantor, Subgrantee shall comply with any demand for <br />repayment, as specified in such final report; <br />ii. Time to response. Subgrantee shall have no more than twenty <br />(20) days from receipt of the final decision to tender payment to <br />Subgrantor or, alternatively, to provide Subgrantor with <br />complete and accurate information or documentary evidence in <br />support of the allowability of questioned costs; <br />iii. Notice after review of further supporting evidence. If <br />Subgrantee challenges questioned costs and submits complete <br />and accurate information or documentary evidence in support of <br />the allowahility of questioned costs as provided above in <br />PICH Subcontract Page 13 <br />CFDA Number: 93.331 <br />Federal Award Identification Number (FAIN): U58DP005861 <br />Grant Number: 1U58DP005861 -01 <br />Funding Opportunity Announcement Number: CDC- RFA -DP14 -1417 <br />20A -15 <br />